wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
ANNRHEUMDIS-2016-210094
ANNRHEUMDIS-2016-210094
http://dx.doi.org/10.1136/ANNRHEUMDIS-2016-210094
Baricitinib in patients with inadequate response or intolerance to conventional synthetic DMARDs: results from the RA-BUILD study.
P356
Q37604501-F7245860-BE2C-4537-B868-BC3689BD8E5B
P356
ANNRHEUMDIS-2016-210094
http://dx.doi.org/10.1136/ANNRHEUMDIS-2016-210094